Antibiotic prescribing on admission to patients with pneumonia and prior outpatient antibiotic treatment: a cohort study on clinical outcome
Open Access
Abstract
Objective Most pneumonia treatment guidelines recommend that prior outpatient antibiotic treatment should be considered when planning inpatient antibiotic regimen. Our purpose was to study in patients admitted for community-acquired pneumonia the mode of continuing antibiotic treatment at the outpatient to inpatient transition and the subsequent clinical course. Design Retrospective cohort study. Setting Dutch PHARMO Record Linkage System. Participants 7323 patients aged >18 years and hospitalised with pneumonia in the Netherlands between 2004 and 2010. Main study parameter We identified all prescribed antibiotics prior to, during and after hospitalisation. In case of prior outpatient treatment, the continuation of antibiotic treatment on admission was categorised as: no atypical coverage > no atypical coverage; atypical coverage > atypical coverage; no atypical coverage > atypical coverage; and atypical coverage > no atypical coverage. Main outcome measures Length of hospital stay, in-hospital mortality and readmission within 30 days. Results Twenty-two per cent of the patients had received prior outpatient treatment, of which 408 (25%) patients were switched on admission to antibiotics with atypical coverage. There were no differences in length of hospital stay, in-hospital mortality or readmission rate between the four categories of patients with prior outpatient treatment. The adjusted HR for adding atypical coverage versus no atypical coverage was 0.91 (95% CI 0.55 to 1.51) for time to discharge. For in-hospital mortality and readmission within 30 days, the adjusted ORs were 1.09 (95% CI 0.85 to 1.34) and 0.59 (95% CI 0.30 to 1.18), respectively. Conclusions This study found no association between mode of continuing antibiotic treatment at the outpatient to inpatient transition and relevant clinical outcomes. In particular, adding atypical coverage in patients without prior atypical coverage did not influence the outcome.Keywords
This publication has 16 references indexed in Scilit:
- Pharmacy‐Based Medical Record Linkage Systems2012
- Guidelines for the management of adult lower respiratory tract infections - Full versionClinical Microbiology and Infection, 2011
- Microbial evaluation of proton-pump inhibitors and the risk of pneumoniaEuropean Respiratory Journal, 2011
- Efficacy of Corticosteroids in Community-acquired Pneumonia: A Randomized Double-Blinded Clinical TrialAmerican Journal of Respiratory and Critical Care Medicine, 2010
- BTS guidelines for the management of community acquired pneumonia in adults: update 2009Thorax, 2009
- Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort studyThorax, 2008
- Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based studyEuropean Journal of Clinical Pharmacology, 2007
- International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumoniaJournal of Clinical Epidemiology, 2007
- Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind studyBMJ, 2006
- Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised studyThorax, 2005